These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3431434

  • 1. C5a receptor.
    Huey R, Hugli TE.
    Methods Enzymol; 1987; 150():615-27. PubMed ID: 3431434
    [No Abstract] [Full Text] [Related]

  • 2. Identification of the polymorphonuclear leukocyte C5a receptor.
    Rollins TE, Springer MS.
    J Biol Chem; 1985 Jun 25; 260(12):7157-60. PubMed ID: 3997862
    [Abstract] [Full Text] [Related]

  • 3. Labeling the granulocyte C5a receptor with a unique photoreactive probe.
    Johnson RJ, Chenoweth DE.
    J Biol Chem; 1985 Jun 25; 260(12):7161-4. PubMed ID: 3997863
    [Abstract] [Full Text] [Related]

  • 4. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
    Barker MD, Jose PJ, Williams TJ, Burton DR.
    Biochem J; 1986 Jun 01; 236(2):621-4. PubMed ID: 3019322
    [Abstract] [Full Text] [Related]

  • 5. Cellular receptors to the anaphylatoxins C3a and C5a.
    Huey R, Fukuoka Y, Hoeprich PD, Hugli TE.
    Biochem Soc Symp; 1986 Jun 01; 51():69-81. PubMed ID: 3545212
    [Abstract] [Full Text] [Related]

  • 6. PMN C5a-receptor down regulation is not involved in recovery from C5a-induced neutropenia.
    Gardinali M, Hugli TE, Ward DM, Agostoni A.
    ASAIO Trans; 1987 Jun 01; 33(3):482-8. PubMed ID: 3499922
    [No Abstract] [Full Text] [Related]

  • 7. Solubilization of the functional C5a receptor from human polymorphonuclear leukocytes.
    Rollins TE, Siciliano S, Springer MS.
    J Biol Chem; 1988 Jan 05; 263(1):520-6. PubMed ID: 3335507
    [Abstract] [Full Text] [Related]

  • 8. Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex.
    Rollins TE, Siciliano S, Kobayashi S, Cianciarulo DN, Bonilla-Argudo V, Collier K, Springer MS.
    Proc Natl Acad Sci U S A; 1991 Feb 01; 88(3):971-5. PubMed ID: 1899485
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
    Huey R, Hugli TE.
    J Immunol; 1985 Sep 01; 135(3):2063-8. PubMed ID: 4020139
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a receptor for C5a anaphylatoxin on human eosinophils.
    Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C.
    J Biol Chem; 1989 Jan 25; 264(3):1760-6. PubMed ID: 2912983
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of a new photoreactive C5a analog that permits identification of the ligand binding component of the granulocyte C5a receptor.
    Johnson RJ, Chenoweth DE.
    Biochem Biophys Res Commun; 1987 Nov 13; 148(3):1330-7. PubMed ID: 3689398
    [Abstract] [Full Text] [Related]

  • 12. Complement C5a receptor assay for high throughput screening.
    Harris SR, Garlick RK, Miller JJ, Harney HN, Monroe PJ.
    J Recept Res; 1991 Nov 13; 11(1-4):115-28. PubMed ID: 1886076
    [Abstract] [Full Text] [Related]

  • 13. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.
    Boulay F, Mery L, Tardif M, Brouchon L, Vignais P.
    Biochemistry; 1991 Mar 26; 30(12):2993-9. PubMed ID: 2007135
    [Abstract] [Full Text] [Related]

  • 14. Identification of an antigenic epitope and receptor binding domain of human C5a.
    Johnson RJ, Tamerius JD, Chenoweth DE.
    J Immunol; 1987 Jun 01; 138(11):3856-62. PubMed ID: 2438329
    [Abstract] [Full Text] [Related]

  • 15. Biological properties of human C5a: selected in vitro and in vivo studies.
    Yancey KB.
    Clin Exp Immunol; 1988 Feb 01; 71(2):207-10. PubMed ID: 3280183
    [No Abstract] [Full Text] [Related]

  • 16. The C5a receptor of neutrophils and macrophages.
    Chenoweth DE, Goodman MG.
    Agents Actions Suppl; 1983 Feb 01; 12():252-73. PubMed ID: 6573117
    [No Abstract] [Full Text] [Related]

  • 17. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity.
    Johnson RJ, Chenoweth DE.
    J Biol Chem; 1985 Aug 25; 260(18):10339-45. PubMed ID: 2410424
    [Abstract] [Full Text] [Related]

  • 18. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
    Kawai M, Quincy DA, Lane B, Mollison KW, Or YS, Luly JR, Carter GW.
    J Med Chem; 1992 Jan 24; 35(2):220-3. PubMed ID: 1732540
    [Abstract] [Full Text] [Related]

  • 19. Reduced expression of C5a receptors on neutrophils from cord blood.
    Nybo M, Sørensen O, Leslie R, Wang P.
    Arch Dis Child Fetal Neonatal Ed; 1998 Mar 24; 78(2):F129-32. PubMed ID: 9577284
    [Abstract] [Full Text] [Related]

  • 20. Structure-function relationships of human C5a and C5aR.
    Huber-Lang MS, Sarma JV, McGuire SR, Lu KT, Padgaonkar VA, Younkin EM, Guo RF, Weber CH, Zuiderweg ER, Zetoune FS, Ward PA.
    J Immunol; 2003 Jun 15; 170(12):6115-24. PubMed ID: 12794141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.